Loading…

Toxicology of 3-epi-deoxynivalenol, a deoxynivalenol-transformation product by Devosia mutans 17-2-E-8

Microbial detoxification of deoxynivalenol (DON) represents a new approach to treating DON-contaminated grains. A bacterium Devosia mutans 17-2-E-8 was capable of completely transforming DON into a major product 3-epi-DON and a minor product 3-keto-DON. Evaluation of toxicities of these DON-transfor...

Full description

Saved in:
Bibliographic Details
Published in:Food and chemical toxicology 2015-10, Vol.84, p.250-259
Main Authors: He, Jian Wei, Bondy, Genevieve S., Zhou, Ting, Caldwell, Don, Boland, Greg J., Scott, Peter M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c434t-8a045938853f7f6d61b28c07a22065c97a74cbbac7f63b4601c8e17ae4c652e53
cites cdi_FETCH-LOGICAL-c434t-8a045938853f7f6d61b28c07a22065c97a74cbbac7f63b4601c8e17ae4c652e53
container_end_page 259
container_issue
container_start_page 250
container_title Food and chemical toxicology
container_volume 84
creator He, Jian Wei
Bondy, Genevieve S.
Zhou, Ting
Caldwell, Don
Boland, Greg J.
Scott, Peter M.
description Microbial detoxification of deoxynivalenol (DON) represents a new approach to treating DON-contaminated grains. A bacterium Devosia mutans 17-2-E-8 was capable of completely transforming DON into a major product 3-epi-DON and a minor product 3-keto-DON. Evaluation of toxicities of these DON-transformation products is an important part of hazard characterization prior to commercialization of the biotransformation application. Cytotoxicities of the products were demonstrated by two assays: a MTT bioassay assessing cell viability and a BrdU assay assessing DNA synthesis. Compared with DON, the IC50 values of 3-epi-DON and 3-keto-DON were respectively 357 and 3.03 times higher in the MTT bioassay, and were respectively 1181 and 4.54 times higher in the BrdU bioassay. Toxicological effects of 14-day oral exposure of the B6C3F1 mouse to DON and 3-epi-DON were also investigated. Overall, there were no differences between the control (free of toxin) and the 25 mg/kg bw/day or 100 mg/kg bw/day 3-epi-DON treatments in body and organ weights, hematology and organ histopathology. However, in mice exposed to DON (2 mg/kg bw/day), white blood cell numbers and serum immunoglobulin levels were altered relative to controls, and lesions were observed in adrenals, thymus, stomach, spleen and colon. Taken together, in vitro and in vivo studies indicate that 3-epi-DON is substantially less toxic than DON. •The IC50 value of 3-epi-DON was 357 times higher than DON in a MTT bioassay.•The IC50 value of 3-epi-DON was 1181 times higher than that of DON in a BrdU assay.•3-epi-DON was at least 50 times less toxic than DON in B6C3F1 mice.
doi_str_mv 10.1016/j.fct.2015.09.003
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1762369692</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278691515300545</els_id><sourcerecordid>1762369692</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-8a045938853f7f6d61b28c07a22065c97a74cbbac7f63b4601c8e17ae4c652e53</originalsourceid><addsrcrecordid>eNqNkU9r3DAQxUVJaTZpP0AvRcccKnck2ZJMTyH_Wgj0kp6FLI-LFtvaSvaS_fZV2LTQS8hpYOY3j5n3CPnIoeLA1ZdtNfilEsCbCtoKQL4hG260ZEo2_IRsQGjDVMubU3KW8xYANNfqHTkVSiopwWzI8BAfg49j_HWgcaCS4S6wHuPjYQ57N-Icx8_U0f87bEluzkNMk1tCnOkuxX71C-0O9Br3MQdHp3UpCOWaCXbDzHvydnBjxg_P9Zz8vL15uPrG7n_cfb-6vGe-lvXCjIO6aaUxjRz0oHrFO2E8aCcEqMa32unad53zZSi7WgH3Brl2WHvVCGzkObk46paTfq-YFzuF7HEc3Yxxzba8L6RqVStegXJTrCsWFpQfUZ9izgkHu0thculgOdinJOzWliTsUxIWWluSKDufnuXXbsL-38Zf6wvw9Qhg8WMfMNnsA84e-5CwiPUxvCD_B_mjmFY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1718915278</pqid></control><display><type>article</type><title>Toxicology of 3-epi-deoxynivalenol, a deoxynivalenol-transformation product by Devosia mutans 17-2-E-8</title><source>Elsevier</source><creator>He, Jian Wei ; Bondy, Genevieve S. ; Zhou, Ting ; Caldwell, Don ; Boland, Greg J. ; Scott, Peter M.</creator><creatorcontrib>He, Jian Wei ; Bondy, Genevieve S. ; Zhou, Ting ; Caldwell, Don ; Boland, Greg J. ; Scott, Peter M.</creatorcontrib><description>Microbial detoxification of deoxynivalenol (DON) represents a new approach to treating DON-contaminated grains. A bacterium Devosia mutans 17-2-E-8 was capable of completely transforming DON into a major product 3-epi-DON and a minor product 3-keto-DON. Evaluation of toxicities of these DON-transformation products is an important part of hazard characterization prior to commercialization of the biotransformation application. Cytotoxicities of the products were demonstrated by two assays: a MTT bioassay assessing cell viability and a BrdU assay assessing DNA synthesis. Compared with DON, the IC50 values of 3-epi-DON and 3-keto-DON were respectively 357 and 3.03 times higher in the MTT bioassay, and were respectively 1181 and 4.54 times higher in the BrdU bioassay. Toxicological effects of 14-day oral exposure of the B6C3F1 mouse to DON and 3-epi-DON were also investigated. Overall, there were no differences between the control (free of toxin) and the 25 mg/kg bw/day or 100 mg/kg bw/day 3-epi-DON treatments in body and organ weights, hematology and organ histopathology. However, in mice exposed to DON (2 mg/kg bw/day), white blood cell numbers and serum immunoglobulin levels were altered relative to controls, and lesions were observed in adrenals, thymus, stomach, spleen and colon. Taken together, in vitro and in vivo studies indicate that 3-epi-DON is substantially less toxic than DON. •The IC50 value of 3-epi-DON was 357 times higher than DON in a MTT bioassay.•The IC50 value of 3-epi-DON was 1181 times higher than that of DON in a BrdU assay.•3-epi-DON was at least 50 times less toxic than DON in B6C3F1 mice.</description><identifier>ISSN: 0278-6915</identifier><identifier>EISSN: 1873-6351</identifier><identifier>DOI: 10.1016/j.fct.2015.09.003</identifier><identifier>PMID: 26363308</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>3-epi-DON ; 3T3 fibroblasts cell line ; Administration, Oral ; Animals ; B6C3F1 mouse ; BrdU bioassay ; Caco-2 cell line ; Caco-2 Cells ; Cell Survival - drug effects ; Crosses, Genetic ; Cytotoxicity ; Deoxynivalenol ; Devosia ; DNA - biosynthesis ; DON ; Dose-Response Relationship, Drug ; Female ; Humans ; Hyphomicrobiaceae - metabolism ; Inactivation, Metabolic ; Kinetics ; Mice ; MTT bioassay ; NIH 3T3 Cells ; Nucleic Acid Synthesis Inhibitors - administration &amp; dosage ; Nucleic Acid Synthesis Inhibitors - chemistry ; Nucleic Acid Synthesis Inhibitors - metabolism ; Nucleic Acid Synthesis Inhibitors - toxicity ; Random Allocation ; Stereoisomerism ; Toxicity Tests, Subacute ; Trichothecenes - administration &amp; dosage ; Trichothecenes - chemistry ; Trichothecenes - metabolism ; Trichothecenes - toxicity ; Vomitoxin</subject><ispartof>Food and chemical toxicology, 2015-10, Vol.84, p.250-259</ispartof><rights>2015</rights><rights>Copyright © 2015. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-8a045938853f7f6d61b28c07a22065c97a74cbbac7f63b4601c8e17ae4c652e53</citedby><cites>FETCH-LOGICAL-c434t-8a045938853f7f6d61b28c07a22065c97a74cbbac7f63b4601c8e17ae4c652e53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26363308$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>He, Jian Wei</creatorcontrib><creatorcontrib>Bondy, Genevieve S.</creatorcontrib><creatorcontrib>Zhou, Ting</creatorcontrib><creatorcontrib>Caldwell, Don</creatorcontrib><creatorcontrib>Boland, Greg J.</creatorcontrib><creatorcontrib>Scott, Peter M.</creatorcontrib><title>Toxicology of 3-epi-deoxynivalenol, a deoxynivalenol-transformation product by Devosia mutans 17-2-E-8</title><title>Food and chemical toxicology</title><addtitle>Food Chem Toxicol</addtitle><description>Microbial detoxification of deoxynivalenol (DON) represents a new approach to treating DON-contaminated grains. A bacterium Devosia mutans 17-2-E-8 was capable of completely transforming DON into a major product 3-epi-DON and a minor product 3-keto-DON. Evaluation of toxicities of these DON-transformation products is an important part of hazard characterization prior to commercialization of the biotransformation application. Cytotoxicities of the products were demonstrated by two assays: a MTT bioassay assessing cell viability and a BrdU assay assessing DNA synthesis. Compared with DON, the IC50 values of 3-epi-DON and 3-keto-DON were respectively 357 and 3.03 times higher in the MTT bioassay, and were respectively 1181 and 4.54 times higher in the BrdU bioassay. Toxicological effects of 14-day oral exposure of the B6C3F1 mouse to DON and 3-epi-DON were also investigated. Overall, there were no differences between the control (free of toxin) and the 25 mg/kg bw/day or 100 mg/kg bw/day 3-epi-DON treatments in body and organ weights, hematology and organ histopathology. However, in mice exposed to DON (2 mg/kg bw/day), white blood cell numbers and serum immunoglobulin levels were altered relative to controls, and lesions were observed in adrenals, thymus, stomach, spleen and colon. Taken together, in vitro and in vivo studies indicate that 3-epi-DON is substantially less toxic than DON. •The IC50 value of 3-epi-DON was 357 times higher than DON in a MTT bioassay.•The IC50 value of 3-epi-DON was 1181 times higher than that of DON in a BrdU assay.•3-epi-DON was at least 50 times less toxic than DON in B6C3F1 mice.</description><subject>3-epi-DON</subject><subject>3T3 fibroblasts cell line</subject><subject>Administration, Oral</subject><subject>Animals</subject><subject>B6C3F1 mouse</subject><subject>BrdU bioassay</subject><subject>Caco-2 cell line</subject><subject>Caco-2 Cells</subject><subject>Cell Survival - drug effects</subject><subject>Crosses, Genetic</subject><subject>Cytotoxicity</subject><subject>Deoxynivalenol</subject><subject>Devosia</subject><subject>DNA - biosynthesis</subject><subject>DON</subject><subject>Dose-Response Relationship, Drug</subject><subject>Female</subject><subject>Humans</subject><subject>Hyphomicrobiaceae - metabolism</subject><subject>Inactivation, Metabolic</subject><subject>Kinetics</subject><subject>Mice</subject><subject>MTT bioassay</subject><subject>NIH 3T3 Cells</subject><subject>Nucleic Acid Synthesis Inhibitors - administration &amp; dosage</subject><subject>Nucleic Acid Synthesis Inhibitors - chemistry</subject><subject>Nucleic Acid Synthesis Inhibitors - metabolism</subject><subject>Nucleic Acid Synthesis Inhibitors - toxicity</subject><subject>Random Allocation</subject><subject>Stereoisomerism</subject><subject>Toxicity Tests, Subacute</subject><subject>Trichothecenes - administration &amp; dosage</subject><subject>Trichothecenes - chemistry</subject><subject>Trichothecenes - metabolism</subject><subject>Trichothecenes - toxicity</subject><subject>Vomitoxin</subject><issn>0278-6915</issn><issn>1873-6351</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNkU9r3DAQxUVJaTZpP0AvRcccKnck2ZJMTyH_Wgj0kp6FLI-LFtvaSvaS_fZV2LTQS8hpYOY3j5n3CPnIoeLA1ZdtNfilEsCbCtoKQL4hG260ZEo2_IRsQGjDVMubU3KW8xYANNfqHTkVSiopwWzI8BAfg49j_HWgcaCS4S6wHuPjYQ57N-Icx8_U0f87bEluzkNMk1tCnOkuxX71C-0O9Br3MQdHp3UpCOWaCXbDzHvydnBjxg_P9Zz8vL15uPrG7n_cfb-6vGe-lvXCjIO6aaUxjRz0oHrFO2E8aCcEqMa32unad53zZSi7WgH3Brl2WHvVCGzkObk46paTfq-YFzuF7HEc3Yxxzba8L6RqVStegXJTrCsWFpQfUZ9izgkHu0thculgOdinJOzWliTsUxIWWluSKDufnuXXbsL-38Zf6wvw9Qhg8WMfMNnsA84e-5CwiPUxvCD_B_mjmFY</recordid><startdate>201510</startdate><enddate>201510</enddate><creator>He, Jian Wei</creator><creator>Bondy, Genevieve S.</creator><creator>Zhou, Ting</creator><creator>Caldwell, Don</creator><creator>Boland, Greg J.</creator><creator>Scott, Peter M.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>201510</creationdate><title>Toxicology of 3-epi-deoxynivalenol, a deoxynivalenol-transformation product by Devosia mutans 17-2-E-8</title><author>He, Jian Wei ; Bondy, Genevieve S. ; Zhou, Ting ; Caldwell, Don ; Boland, Greg J. ; Scott, Peter M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-8a045938853f7f6d61b28c07a22065c97a74cbbac7f63b4601c8e17ae4c652e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>3-epi-DON</topic><topic>3T3 fibroblasts cell line</topic><topic>Administration, Oral</topic><topic>Animals</topic><topic>B6C3F1 mouse</topic><topic>BrdU bioassay</topic><topic>Caco-2 cell line</topic><topic>Caco-2 Cells</topic><topic>Cell Survival - drug effects</topic><topic>Crosses, Genetic</topic><topic>Cytotoxicity</topic><topic>Deoxynivalenol</topic><topic>Devosia</topic><topic>DNA - biosynthesis</topic><topic>DON</topic><topic>Dose-Response Relationship, Drug</topic><topic>Female</topic><topic>Humans</topic><topic>Hyphomicrobiaceae - metabolism</topic><topic>Inactivation, Metabolic</topic><topic>Kinetics</topic><topic>Mice</topic><topic>MTT bioassay</topic><topic>NIH 3T3 Cells</topic><topic>Nucleic Acid Synthesis Inhibitors - administration &amp; dosage</topic><topic>Nucleic Acid Synthesis Inhibitors - chemistry</topic><topic>Nucleic Acid Synthesis Inhibitors - metabolism</topic><topic>Nucleic Acid Synthesis Inhibitors - toxicity</topic><topic>Random Allocation</topic><topic>Stereoisomerism</topic><topic>Toxicity Tests, Subacute</topic><topic>Trichothecenes - administration &amp; dosage</topic><topic>Trichothecenes - chemistry</topic><topic>Trichothecenes - metabolism</topic><topic>Trichothecenes - toxicity</topic><topic>Vomitoxin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>He, Jian Wei</creatorcontrib><creatorcontrib>Bondy, Genevieve S.</creatorcontrib><creatorcontrib>Zhou, Ting</creatorcontrib><creatorcontrib>Caldwell, Don</creatorcontrib><creatorcontrib>Boland, Greg J.</creatorcontrib><creatorcontrib>Scott, Peter M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Food and chemical toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>He, Jian Wei</au><au>Bondy, Genevieve S.</au><au>Zhou, Ting</au><au>Caldwell, Don</au><au>Boland, Greg J.</au><au>Scott, Peter M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Toxicology of 3-epi-deoxynivalenol, a deoxynivalenol-transformation product by Devosia mutans 17-2-E-8</atitle><jtitle>Food and chemical toxicology</jtitle><addtitle>Food Chem Toxicol</addtitle><date>2015-10</date><risdate>2015</risdate><volume>84</volume><spage>250</spage><epage>259</epage><pages>250-259</pages><issn>0278-6915</issn><eissn>1873-6351</eissn><abstract>Microbial detoxification of deoxynivalenol (DON) represents a new approach to treating DON-contaminated grains. A bacterium Devosia mutans 17-2-E-8 was capable of completely transforming DON into a major product 3-epi-DON and a minor product 3-keto-DON. Evaluation of toxicities of these DON-transformation products is an important part of hazard characterization prior to commercialization of the biotransformation application. Cytotoxicities of the products were demonstrated by two assays: a MTT bioassay assessing cell viability and a BrdU assay assessing DNA synthesis. Compared with DON, the IC50 values of 3-epi-DON and 3-keto-DON were respectively 357 and 3.03 times higher in the MTT bioassay, and were respectively 1181 and 4.54 times higher in the BrdU bioassay. Toxicological effects of 14-day oral exposure of the B6C3F1 mouse to DON and 3-epi-DON were also investigated. Overall, there were no differences between the control (free of toxin) and the 25 mg/kg bw/day or 100 mg/kg bw/day 3-epi-DON treatments in body and organ weights, hematology and organ histopathology. However, in mice exposed to DON (2 mg/kg bw/day), white blood cell numbers and serum immunoglobulin levels were altered relative to controls, and lesions were observed in adrenals, thymus, stomach, spleen and colon. Taken together, in vitro and in vivo studies indicate that 3-epi-DON is substantially less toxic than DON. •The IC50 value of 3-epi-DON was 357 times higher than DON in a MTT bioassay.•The IC50 value of 3-epi-DON was 1181 times higher than that of DON in a BrdU assay.•3-epi-DON was at least 50 times less toxic than DON in B6C3F1 mice.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>26363308</pmid><doi>10.1016/j.fct.2015.09.003</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0278-6915
ispartof Food and chemical toxicology, 2015-10, Vol.84, p.250-259
issn 0278-6915
1873-6351
language eng
recordid cdi_proquest_miscellaneous_1762369692
source Elsevier
subjects 3-epi-DON
3T3 fibroblasts cell line
Administration, Oral
Animals
B6C3F1 mouse
BrdU bioassay
Caco-2 cell line
Caco-2 Cells
Cell Survival - drug effects
Crosses, Genetic
Cytotoxicity
Deoxynivalenol
Devosia
DNA - biosynthesis
DON
Dose-Response Relationship, Drug
Female
Humans
Hyphomicrobiaceae - metabolism
Inactivation, Metabolic
Kinetics
Mice
MTT bioassay
NIH 3T3 Cells
Nucleic Acid Synthesis Inhibitors - administration & dosage
Nucleic Acid Synthesis Inhibitors - chemistry
Nucleic Acid Synthesis Inhibitors - metabolism
Nucleic Acid Synthesis Inhibitors - toxicity
Random Allocation
Stereoisomerism
Toxicity Tests, Subacute
Trichothecenes - administration & dosage
Trichothecenes - chemistry
Trichothecenes - metabolism
Trichothecenes - toxicity
Vomitoxin
title Toxicology of 3-epi-deoxynivalenol, a deoxynivalenol-transformation product by Devosia mutans 17-2-E-8
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T21%3A00%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Toxicology%20of%203-epi-deoxynivalenol,%20a%20deoxynivalenol-transformation%20product%20by%20Devosia%20mutans%2017-2-E-8&rft.jtitle=Food%20and%20chemical%20toxicology&rft.au=He,%20Jian%20Wei&rft.date=2015-10&rft.volume=84&rft.spage=250&rft.epage=259&rft.pages=250-259&rft.issn=0278-6915&rft.eissn=1873-6351&rft_id=info:doi/10.1016/j.fct.2015.09.003&rft_dat=%3Cproquest_cross%3E1762369692%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c434t-8a045938853f7f6d61b28c07a22065c97a74cbbac7f63b4601c8e17ae4c652e53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1718915278&rft_id=info:pmid/26363308&rfr_iscdi=true